Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2000-1-6
pubmed:abstractText
Neuropeptide Y (NPY) is known to induce robust feeding through the action of NPY receptors in the hypothalamus. Among the subtypes of NPY receptors, Y(1) receptors may play a key role in feeding regulation. In the present study, we demonstrated that a novel Y(1) antagonist, J-104870, shows high selectivity and potency for the Y(1) receptor with an anorexigenic effect on NPY-mediated feeding. J-104870 displaced [(125)I]peptide YY (PYY) binding to cloned human and rat Y(1) receptors with K(i) values of 0.29 and 0.54 nM, respectively, and inhibited the NPY (10 nM)-induced increase in intracellular calcium levels (IC(50) = 3.2 nM) in cells expressing human Y(1) receptors. In contrast, J-104870 showed low affinities for human Y(2) (K(i) > 10 microM), Y(4) (K(i) > 10 microM), and Y(5) receptors (K(i) = 6 microM). In rat hypothalamic membranes, J-104870 also completely displaced the binding of [(125)I]1229U91, which is known to bind to the typical Y(1) receptor, with a high affinity (K(i) = 2.0 nM). Intracerebroventricular (ICV) injection of J-104870 (200 microg) significantly suppressed NPY (5 microg)-induced feeding in satiated Sprague-Dawley rats by 74%. Furthermore, ICV and oral administration of J-104870 (200 microg and 100 mg/kg, respectively) significantly suppressed spontaneous food intake in Zucker fatty rats. These findings suggested that J-104870 is a selective and potent nonpeptide Y(1) antagonist with oral bioavailability and brain penetrability. In addition, the anorexigenic effect of J-104870 clearly revealed the participation of the Y(1) receptor in NPY-mediated feeding regulation. The potent and orally active Y(1) antagonist J-104970 is a useful tool for elucidating the physiological roles of NPY in obesity.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0006-291X
pubmed:author
pubmed:copyrightInfo
Copyright 1999 Academic Press.
pubmed:issnType
Print
pubmed:day
9
pubmed:volume
266
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
88-91
pubmed:dateRevised
2005-11-17
pubmed:meshHeading
pubmed-meshheading:10581170-Administration, Oral, pubmed-meshheading:10581170-Animals, pubmed-meshheading:10581170-Binding, Competitive, pubmed-meshheading:10581170-Biological Availability, pubmed-meshheading:10581170-Brain, pubmed-meshheading:10581170-CHO Cells, pubmed-meshheading:10581170-Carbamates, pubmed-meshheading:10581170-Cell Membrane, pubmed-meshheading:10581170-Cricetinae, pubmed-meshheading:10581170-Feeding Behavior, pubmed-meshheading:10581170-Hippocampus, pubmed-meshheading:10581170-Humans, pubmed-meshheading:10581170-Inhibitory Concentration 50, pubmed-meshheading:10581170-Injections, Intraventricular, pubmed-meshheading:10581170-Male, pubmed-meshheading:10581170-Neuropeptide Y, pubmed-meshheading:10581170-Rats, pubmed-meshheading:10581170-Rats, Sprague-Dawley, pubmed-meshheading:10581170-Rats, Zucker, pubmed-meshheading:10581170-Receptors, Neuropeptide Y, pubmed-meshheading:10581170-Thiazoles, pubmed-meshheading:10581170-Time Factors
pubmed:year
1999
pubmed:articleTitle
The novel neuropeptide Y Y(1) receptor antagonist J-104870: a potent feeding suppressant with oral bioavailability.
pubmed:affiliation
Banyu Tsukuba Research Institute, Banyu Pharmaceutical Co., Ltd., Okubo 3, Tsukuba, 300-2611, Japan. kantniak@banyu.co.jp
pubmed:publicationType
Journal Article